The price of robustness; impact of worst-case optimization on organ-at-risk dose and complication probability in intensity-modulated proton therapy for oropharyngeal cancer patients
To quantify the impact of the degree of robustness against setup errors and range errors on organ-at-risk (OAR) dose and normal tissue complication probabilities (NTCPs) in intensity-modulated proton therapy for oropharyngeal cancer patients.
Source: Radiotherapy and Oncology - Category: Radiology Authors: Steven van de Water, Iris van Dam, Dennis R. Schaart, Abrahim Al-Mamgani, Ben J.M. Heijmen, Mischa S. Hoogeman Tags: Original article Source Type: research